CASP6 and chronic myelogenous leukemia, BCR-ABL1 positive: As demonstrated in Fig. 6a, R-CR8 or S-CR8 as well as MR4 treatment of CML cell lines induced activation of initiator procaspases 2, 8, 9 and 10, as well as other effector caspases 6 and 7.